0001415889-24-000277.txt : 20240103 0001415889-24-000277.hdr.sgml : 20240103 20240103161525 ACCESSION NUMBER: 0001415889-24-000277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Kevin M. CENTRAL INDEX KEY: 0001971303 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 24506558 MAIL ADDRESS: STREET 1: C/O XILIO THERAPEUTICS, INC. STREET 2: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-01032024_040103.xml X0508 4 2024-01-01 0001840233 Xilio Therapeutics, Inc. XLO 0001971303 Brennan Kevin M. 828 WINTER STREET SUITE 300 WALTHAM MA 02451 false true false false SVP, FINANCE AND ACCOUNTING 0 Restricted Stock Units 2024-01-01 4 A 0 20000 0 A Common Stock 20000 20000 D Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock. These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028. /s/ Julia Walcott, Attorney-in-Fact 2024-01-03